InvestorsHub Logo
Followers 7
Posts 3296
Boards Moderated 0
Alias Born 05/30/2013

Re: tebow4ever post# 72625

Tuesday, 02/21/2017 6:28:09 PM

Tuesday, February 21, 2017 6:28:09 PM

Post# of 132362
MJ Industry is growing, take a look..

AmeriCann Added to LD Micro Index and Proposed Cannabis ETF Emerging AgroSphere

DENVER, CO -- February 21, 2017 -- InvestorsHub NewsWire -- AmeriCann, Inc. (OTCQX: ACAN), an Ag-Tech company that is developing sustainable, state-of-the-art medical cannabis cultivation properties, is pleased to announce it has been added to the LD Micro Index as of February 1st, 2017. In addition, AmeriCann is included in the proposed first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF.
The LD Micro Index is designed to give the most accurate representation of the intraday activity of microcap stocks in North America. Criteria for inclusion can be found at the following link: http://www.ldmicro.com/the-index
The index is market cap weighted and is comprised of approximately 1,000 stocks in the U.S. and Canada. Included stocks have a market capitalization between $50 million and $300 million and an average daily traded value of $50,000 over the preceding 3 months.
LD Micros David Scher stated, "We have been monitoring AmeriCann for some time now and are truly pleased to see them included in the index. This is a company that has performed incredibly well from a business perspective, as well as an investment perspective."
ETF Managers Group, based in Summit, New Jersey, has filed an initial registration statement for what could be the first cannabis exchange-traded fund (ETF), the Emerging AgroSphere ETF. The proposed fund will be focused on medical cannabis and will not invest in any companies that are focused on serving the non-medical marijuana market in the United States, Canada or any other country unless and until such time as the production and sale of non-medical marijuana becomes legal in the United States, Canada or such other country, respectively.
AmeriCann is developing a 53-acre property in Massachusetts (acquired from Boston Beer Company (SAM-NYSE) for $4,475,000 in cash), as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC is approved for 1 million square feet and is expected to be one of the largest and most technologically advanced cannabis cultivation facilities in the nation.
The regulated cannabis industry is one of the fastest growing industries in the country. The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the industry from the current $7 billion nationally to over $50 billion in ten years.
Massachusetts, California, Maine, and Nevada voted to legalize recreational marijuana while Arkansas and North Dakota approved medical cannabis initiatives.  Florida voters approved medical marijuana in a landslide with over 71% of the vote.  With these election results, over 60% of the US Population now live in states where medical cannabis is now legal.
 
About AmeriCann
AmeriCann is a publicly traded Ag-Tech company that is developing and sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the companys commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co or follow AmeriCann on Twitter @ACANinfo